Titan Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
7.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.22
|
0.00
|
0.22
|
100.00%
|
|
2022-09-30
|
-0.21
|
-0.18
|
0.03
|
14.29%
|
|
2022-06-30
|
-0.26
|
-0.18
|
0.08
|
30.77%
|
|
2022-03-31
|
-0.35
|
-0.26
|
0.09
|
25.71%
|
|
2021-12-31
|
0.00
|
-0.26
|
0.00
|
0.00%
|
|
2021-09-30
|
-0.35
|
-0.19
|
0.16
|
45.71%
|
|
2021-06-30
|
-0.35
|
-0.17
|
0.18
|
51.43%
|
|
2021-03-31
|
-0.85
|
-0.28
|
0.57
|
67.06%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.62
|
|
2021-12-31
|
-0.90
|
|
2020-12-31
|
-5.96
|
|
2019-12-31
|
-37.80
|
|
2018-12-31
|
-5.27
|
|
2016-12-31
|
-0.56
|
|
2015-12-31
|
-0.53
|
|
2014-12-31
|
-20.40
|
|
2013-12-31
|
-2.88
|
|
2012-12-31
|
-235.17
|
|
2011-12-31
|
-253.89
|
|
2010-12-31
|
-93.46
|
|
2008-12-31
|
-114.96
|
|
2007-12-31
|
-13.53
|
|
2006-12-31
|
-13.86
|
|
2005-12-31
|
-22.77
|
|
2004-12-31
|
-27.39
|
|
2003-12-31
|
-31.02
|
|
2002-12-31
|
-33.33
|
|
2001-12-31
|
-20.79
|
|
2000-12-31
|
-17.49
|
|
1999-12-31
|
-23.10
|
|
1998-12-31
|
-31.02
|
|
1997-12-31
|
-10.23
|